CERTIFICATE OF ANALYSISCS0897_202182-003_C

Client Sample ID: 200131TNFL500c PureEVIE

1204 Village Market Pl #226

Morrisville, NC 27560

Receive sample: 31-Jan-20

Initiate analyses: 03-Feb-20

Analyst: Signature: Date:

Reviewed by: Signature: Date:

Test Type: Total Cannabinoid Profile

Technical Procedure: TP A0033 & A0049

Results:

Chemical

Analyzed% Weight

Concentration

(mg/g)

CBN <0.01 <0.10

Δ9 THC 0.08 0.76

CBDV <0.01 <0.10 C:\Users\Dave Minser\Google Drive\02 Avazyme Controlled Substances\Pictures\2020\202182-003.jpg

CBG 0.03 0.31

CBD 2.00 20.02

CBC 0.11 1.06

CBDA 0.19 1.93

CBGA <0.01 <0.10

THCA <0.01 <0.10

THCV <0.01 <0.10

* total THC 0.08 0.76

* total CBD 2.17 21.71

total 2.42 24.16

28.6

* total THC is calculated by Δ9 THC + 0.877xTHCA

* total CBD is calculated by CBD + 0.877xCBDA

Cannabinoids

Concentration of cannabinoids were determined by Shimadzu LC2030 Plus with an Avazyme intra lab validated method utilizing certified reference standards for

each chemical analyzed.

The result applies only to the sample listed on this certificate. Avazyme cannot guarantee that this sample is representative of the product/lot as a whole.

Avazyme warrants that this study was performed in accordance with appropriate laboratory research practices and protocols for the sample submitted.

Avazyme is not responsible for Sponsor's use of the information or concepts generated as part of the study, and will not be liable for any loss or damage resulting

from such use.

Dave Minser

Jacob Edwards

Sample Description: PureFULL 500 mg + organic cinnamon

ratio: Total CBD/THC

<0.0

1

0.0

8

<0.0

1

0.0

3

2.0

0

0.1

1

0.1

9

<0.0

1

<0.0

1

<0.0

1

C B N Δ 9 T H C C B D V C B G C B D C B C C B D A C B G A T H C A T H C V

WEI

GH

T P

ERC

ENT

CHEMICAL

Avazyme, Inc. 2202 Ellis Rd Suite A, Durham, NC 27703 www.avazyme.com Page 1 of 1

DocuSign Envelope ID: CA88EBCF-D387-4240-8A0A-E1208174992D

04-Feb-2020 | 17:32 EST

05-Feb-2020 | 13:19 EST